ASXL1 mutations are prognostically significant in PMF, but not MF following essential thrombocythemia or polycythemia vera
ASXL1 mutations are prognostically significant in PMF, but not MF following essential thrombocythemia or polycythemia vera / Guglielmelli, Paola; Coltro, Giacomo; Mannelli, Francesco; Rotunno, Giada; Loscocco, Giuseppe G; Mannarelli, Carmela; Maccari, Chiara; Paoli, Chiara; Romagnoli, Simone; Bartalucci, Niccolò; Vannucchi, Alessandro M. - In: BLOOD ADVANCES. - ISSN 2473-9537. - ELETTRONICO. - 6:(2022), pp. 2927-2931. [10.1182/bloodadvances.2021006350]
ASXL1 mutations are prognostically significant in PMF, but not MF following essential thrombocythemia or polycythemia vera
Guglielmelli, PaolaWriting – Original Draft Preparation
;Coltro, GiacomoWriting – Original Draft Preparation
;Mannelli, FrancescoWriting – Review & Editing
;Rotunno, GiadaData Curation
;Loscocco, Giuseppe GWriting – Review & Editing
;Mannarelli, CarmelaData Curation
;Maccari, ChiaraData Curation
;Paoli, ChiaraWriting – Review & Editing
;Romagnoli, SimoneFormal Analysis
;Bartalucci, NiccolòData Curation
;Vannucchi, Alessandro MWriting – Original Draft Preparation
2022
Abstract
ASXL1 mutations are prognostically significant in PMF, but not MF following essential thrombocythemia or polycythemia vera
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Gugleilmelli_ASXL1advancesADV2021006350.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Creative commons
Dimensione
838.92 kB
Formato
Adobe PDF
|
838.92 kB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
